GlassScriptPhysician profile
Karen Saravanos
NPI 1497743793
$1,266.00
in general payments reported to CMS, 2019-2025
18 companies · $44.44 in 2025
The $44.44 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.36 · 2020: $75.04 · 2021: $234 · 2022: $392 · 2023: $156 · 2024: $295 · 2025: $44.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.13 |
| Education | $118.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $298.29 | 2022-2025 | Veozah |
| Pfizer INC. | $222.55 | 2021-2023 | |
| Abbvie INC. | $167.37 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $89.30 | 2023-2024 | Acessa Provu System, Omni Hysteroscope, Novasure |
| Coopersurgical, INC. | $72.81 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $66.52 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $48.26 | 2019-2020 | |
| Amgen INC. | $47.54 | 2021 | |
| Myovant Sciences INC. | $44.88 | 2021-2022 | |
| Heron Therapeutics, INC. | $44.38 | 2022 | |
| Therapeuticsmd, INC. | $28.83 | 2020 | |
| Mayne Pharma Commercial LLC | $27.88 | 2021-2022 | |
| Medtronic, INC. | $22.73 | 2025 | Truclear |
| Evofem Biosciences, INC. | $21.19 | 2022 | |
| Lupin INC. | $18.73 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.56 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.93 | 2020 | |
| Millicent US INC | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Saravanos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.